Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
about
Human papillomavirus 16 oncoprotein E7 stimulates UBF1-mediated rDNA gene transcription, inhibiting a p53-independent activity of p14ARFThe human papillomavirus type 58 E7 oncoprotein modulates cell cycle regulatory proteins and abrogates cell cycle checkpoints.Critical roles for non-pRb targets of human papillomavirus type 16 E7 in cervical carcinogenesisHuman papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis.HPV episome levels are potently decreased by pyrrole-imidazole polyamides.E6 and E7 from human papillomavirus type 16 cooperate to target the PDZ protein Na/H exchange regulatory factor 1.Recent Insights into the Control of Human Papillomavirus (HPV) Genome Stability, Loss, and Degradation.Role of Cdk1 in DNA damage-induced G1 checkpoint abrogation by the human papillomavirus E7 oncogene.Recent advances in the search for antiviral agents against human papillomaviruses.Molecular mechanisms of human papillomavirus-induced carcinogenesis.RNA interference for the treatment of papillomavirus disease.Five years of progress on cyclin-dependent kinases and other cellular proteins as potential targets for antiviral drugs.Cellular transformation by human papillomaviruses: lessons learned by comparing high- and low-risk virusesThe papillomavirus E7 proteins.Oncogenic activities of human papillomaviruses.The human papillomavirus E7 oncoprotein.Manipulation of cellular DNA damage repair machinery facilitates propagation of human papillomaviruses.Global effects of human papillomavirus type 18 E6/E7 in an organotypic keratinocyte culture system.Inhibition of HPV-16 E7 oncogenic activity by HPV-16 E2.Human papillomavirus type 16 E7 oncoprotein associates with the centrosomal component gamma-tubulin.The HPV-16 E7 oncoprotein induces centriole multiplication through deregulation of Polo-like kinase 4 expression.Direct association of the HPV16 E7 oncoprotein with cyclin A/CDK2 and cyclin E/CDK2 complexes.
P2860
Q33567807-3773212D-FEC7-4CA6-8E98-D7594F52B7D6Q33638499-BC2FC80C-0906-4307-BAD4-0167282C0F22Q33805184-08C048BE-8797-4E81-BFF1-3DE9AA3E660AQ33805208-600900BD-6EAB-4EEC-958D-2AFA3CF21387Q33931195-2240AF5E-FE86-436B-BD53-7125A7F8BB75Q35140477-3741DE54-9AF5-4EFD-9FDC-FBE294CB3630Q35195553-DA0751F8-1642-462B-8087-D89C5427E265Q36187434-F61B1A64-4CEB-4506-90AE-DE93EB1CF135Q36284493-58B9DFFD-55AC-4C5A-93FE-F49AE636CC46Q36303426-35EAE3C6-78BB-47BE-8B2B-2F595A1BB5B7Q36540664-3A2AEBF5-A795-4C11-87F3-8CBB04E4A1C0Q36716750-2AD289DF-F220-421E-830D-DDE06E41DCE7Q36989890-A2833FBD-0C5B-456C-A9DB-1E47601E5A11Q37198662-0E8E49DE-B026-4810-8B2E-D6B1750ADCF0Q37316158-F8EBD1DB-3C44-49E4-B61C-A7E2D35D19C0Q37325199-DCE8B290-47C0-40B4-A3DA-6AD1F6677CABQ38177526-96727E92-85D8-46AC-9F1B-3C675DEB5B6AQ38337784-CA815861-8705-4E59-9BD2-53B6B1CDEBCDQ39855654-C5F272DC-A941-4B46-9C59-B24000AA183CQ40072482-6C73D9DD-0C47-4090-A40A-46056A401E38Q41827384-417D53BB-63FF-4975-B26C-A0F37E2CFF2EQ43250013-01D018D1-B1BF-4087-9237-94172B55DA7E
P2860
Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
@en
type
label
Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
@en
prefLabel
Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
@en
P2093
P2860
P1433
P1476
Direct activation of cyclin-dependent kinase 2 by human papillomavirus E7.
@en
P2093
Chris Fisher
Clark Smith
Doug Staples
P2860
P304
10566-10574
P356
10.1128/JVI.77.19.10566-10574.2003
P407
P577
2003-10-01T00:00:00Z